STELLARIS PHARMACEUTICALS ApS
CVR 34708215 · Private limited company (ApS) · Active · Low risk
STELLARIS PHARMACEUTICALS ApS is a Private limited company (ApS), founded on , based in København V. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 13 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -3.6m and a net result of DKK -595k. CEO: Birgit Ter-Borch Gram Lilienfeldt Schjoldager.
Bankruptcy risk for STELLARIS PHARMACEUTICALS ApS
0.4 × the average (1.41%) · higher risk than 66% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 34708215
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (14 years)
- Address
- Værnedamsvej 10, 4. tv
1619 København V - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 80k
- Auditor
- Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 13 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -275.1% |
| Current ratio | 20% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 17 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -475k | DKK -336k |
| Net profit | DKK -595k | DKK -487k |
| Equity | DKK -3.6m | DKK -3.0m |
| Total assets | DKK 1.3m | DKK 989k |
| Cash | DKK 530k | – |
| Short-term debt | DKK 4.9m | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 148 | ||
| 1 Jan 2024 – 31 Dec 2024 | 44 | ||
| 1 Jan 2023 – 31 Dec 2023 | 121 | ||
| 1 Jan 2022 – 31 Dec 2022 | 61 | ||
| 1 Jan 2021 – 31 Dec 2021 | 165 | ||
| 1 Jan 2020 – 31 Dec 2020 | 102 | ||
| 1 Jan 2019 – 31 Dec 2019 | 73 | ||
| 1 Jan 2018 – 31 Dec 2018 | 143 | ||
| 1 Jan 2017 – 31 Dec 2017 | 98 | ||
| 1 Jan 2016 – 31 Dec 2016 | 123 | ||
| 1 Jan 2015 – 31 Dec 2015 | 60 | ||
| 1 Jan 2014 – 31 Dec 2014 | 104 | ||
| 21 Sep 2012 – 31 Dec 2013 | 143 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Birgit Ter-Borch Gram Lilienfeldt Schjoldager | Current | |
| Owner (100%) | Ranoda Holding ApS | Current | |
| Owner (100%) | DANORA ApS | ||
| Owner (50%) | Danora Invest ApS | ||
| Auditor | HENRICHSEN & CO HOLDING 1 ApS | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | ||
| Founder | DANORA ApS | Current |
The CEOs' other companies
Birgit Ter-Borch Gram Lilienfeldt Schjoldager – 1 other companies
- DANORA ApS Active
Address history (5 moves)
| Værnedamsvej 10, 4. tv, 1619 København V | |
| c/o Lyngen Erhvervsservice, Borupvang 3, 2750 Ballerup | |
| c/o Treville & Co A/S, Kongens Nytorv 22, 4., 1050 København K | |
| c/o Beierholm, Knud Højgaards Vej 9, 2860 Søborg | |
| c/o Beierholm, Gribskovvej 2, 2100 København Ø | |
| c/o Henrichsen & Co Statsautoriseret Revisio, Wildersgade 10 b, 1408 København K |
Other companies at the same address
- Andi Debel Holding IVS Bankrupt
- GEIGERPLUS IVS Bankrupt
- LOVESHOWER HOLDING IVS Bankrupt
- PAUSE ApS Bankrupt
- Taiji Trading IVS Bankrupt
- Trine Bøttger Holding IVS Bankrupt
- ALPA HOLDING ApS Opløst
- Getting Green ApS Active
- Graziano V10 ApS Active
- Italo Bar ApS Active
- Mirror Film ApS Active
- Nordic Agency Group ApS Active
- OPUS ApS Opløst
- Ranoda Holding ApS Active
- Top10hundrede ApS Active
- Wolff DK Holding Aps Active
- Wolffie ApS Fusioneret
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about STELLARIS PHARMACEUTICALS ApS
Has STELLARIS PHARMACEUTICALS ApS gone bankrupt?
No, STELLARIS PHARMACEUTICALS ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of STELLARIS PHARMACEUTICALS ApS?
Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of STELLARIS PHARMACEUTICALS ApS?
Birgit Ter-Borch Gram Lilienfeldt Schjoldager is the CEO of STELLARIS PHARMACEUTICALS ApS.
Who is the auditor of STELLARIS PHARMACEUTICALS ApS?
STELLARIS PHARMACEUTICALS ApS most recently used Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab.
When was STELLARIS PHARMACEUTICALS ApS founded?
STELLARIS PHARMACEUTICALS ApS was founded on 21 September 2012.
What is the equity of STELLARIS PHARMACEUTICALS ApS?
Equity was DKK -3.6m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.